BML Capital Management »

Pieris Pharmaceuticals shares owned by BML Capital Management

Quarter-by-quarter ownership of Pieris Pharmaceuticals (PIRS) shares owned by BML Capital Management from 13F filings

Historical chart of BML Capital Management investment in Pieris Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Pieris Pharmaceuticals held by BML Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pieris Pharmaceuticals by BML Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $699k 42k 16.58

More positions owned by BML Capital Management

Ishares Tr 0-3 Mnth Treasry (SGOV)
Instil Bio Com New (TIL)
Atea Pharmaceuticals (AVIR)
Aclaris Therapeutics (ACRS)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Adverum Biotechnologies Com New (ADVM)
Tectonic Therapeutic (TECX)
An2 Therapeutics (ANTX)
Reneo Pharmaceuticals (RPHM)
Oramed Pharmaceuticals Com New (ORMP)
Achilles Therapeutics Sponsored Ads (ACHL)
Aadi Bioscience (AADI)
Connect Biopharma Hldgs Ads (CNTB)
Pmv Pharmaceuticals (PMVP)
Astrotech Corp (ASTC)

View all positions for BML Capital Management

Top funds holding Pieris Pharmaceuticals

BVF
BML Capital Management
Lynx1 Capital Management
Renaissance Technologies
CM Management
Frazier Life Sciences Management
BlackRock
BlackRock
Geode Capital Management
Citadel Advisors
Vanguard Group
Acadian Asset Management
Citigroup
Tower Research Capital
Group One Trading

View all funds holding Pieris Pharmaceuticals